PBPK modeling to evaluate maximum tolerated doses: A case study with 3-chloroallyl alcohol.
Front Pharmacol
; 14: 1088011, 2023.
Article
in En
| MEDLINE
| ID: mdl-36909196
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
/
Qualitative_research
Language:
En
Journal:
Front Pharmacol
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: